| Assessment Status | Assessment process complete |
| HTA ID | - |
| Drug | Ferumoxytol |
| Brand | Rienso® |
| Indication | For the treatment of iron deficiency anaemia in adult patients with chronic kidney disease (CKD). |
| Assessment Process | |
| Full pharmacoeconomic assessment commissioned by HSE | 12/08/2012 |
| NCPE assessment completed | 17/08/2012 |
| NCPE assessment outcome | Full pharmacoeconomic evaluation not recommended. |